Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-O-gallate in L-929 cells.

Many in vitro studies about green tea polyphenol, (-)-epigallocatechin-3-O-gallate (EGCG) focused on its pro-apoptotic and anti-proliferative effects on various types of cancer cells, while less attention has been paid to its incorporation into the cytoplasm and nuclear translocation. This study concentrated on the time-dependent intracellular trafficking of EGCG in L-929 cells. EGCG was conjugated with fluorescein-4-isothiocyanate (FITC) via the 3''-OH or 5''-OH group, as confirmed by NMR analysis, and then treated to either suspended or cultured cells. Confocal microscopic observations revealed that FITC-EGCG was clearly seen onto the membrane of suspended cells as well as into the cytoplasm and nucleus within 1h. As an increase in treatment time, it concentrated on the nucleus and then was located at any places of the cells. The cellular uptake of FITC-EGCG in cultured cells was not observed until 1h of culture, but started to be observed after at least 2h. These results imply that although the cellular sensitivity and response to EGCG would be different from those of FITC-EGCG, it would be incorporated into the cytoplasm of cells and further be translocated into the nucleus in a time-dependent manner.

[1]  S. Nikolaou,et al.  Synthesis and spectral investigation of Al(III) catechin/beta-cyclodextrin and Al(III) quercetin/beta-cyclodextrin inclusion compounds. , 2008, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[2]  S. Amin,et al.  Synthesis of (-)-[4-3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration. , 2001, Journal of agricultural and food chemistry.

[3]  W. Jin,et al.  Determination of different forms of human interferon‐γ in single natural killer cells by capillary electrophoresis with on‐capillary immunoreaction and laser‐induced fluorescence detection , 2004, Electrophoresis.

[4]  S. Usanov,et al.  Oxidative modification of quercetin by hemeproteins. , 2006, Biochemical and biophysical research communications.

[5]  A. Chan,et al.  A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]. , 2004, Bioorganic & medicinal chemistry.

[6]  J. Crowell,et al.  Absorption, Tissue Distribution and Elimination of 4-[3H]-Epigallocatechin Gallate in Beagle Dogs , 2003, International journal of toxicology.

[7]  Gang Lu,et al.  Molecular targets for the cancer preventive activity of tea polyphenols , 2006, Molecular carcinogenesis.

[8]  Hong-yu Zhang,et al.  Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. , 2007, Molecules.

[9]  Y. Hashimoto,et al.  Antiproliferative and apoptosis-inducing activities of alkyl gallate and gallamide derivatives related to (-)-epigallocatechin gallate. , 2008, Bioorganic & medicinal chemistry.

[10]  T. Kuzuhara,et al.  DNA and RNA as New Binding Targets of Green Tea Catechins* , 2006, Journal of Biological Chemistry.

[11]  A. Napolitano,et al.  The acid-promoted reaction of the green tea polyphenol epigallocatechin gallate with nitrite ions. , 2005, Chemical research in toxicology.

[12]  A. Komori,et al.  Mechanisms of Growth Inhibition of Human Lung Cancer Cell Line, PC‐9, by Tea Polyphenols , 1997, Japanese journal of cancer research : Gann.

[13]  Koji Yamada,et al.  Green Tea Polyphenol Epigallocatechin-3-gallate Signaling Pathway through 67-kDa Laminin Receptor* , 2008, Journal of Biological Chemistry.

[14]  A. Bode,et al.  The Intermediate Filament Protein Vimentin Is a New Target for Epigallocatechin Gallate* , 2005, Journal of Biological Chemistry.

[15]  T. Gasiewicz,et al.  Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. , 2005, Biochemistry.

[16]  Xiaofeng Meng,et al.  Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. , 2002, Cancer research.

[17]  Yoshinori Uekusa,et al.  Dynamic behavior of tea catechins interacting with lipid membranes as determined by NMR spectroscopy. , 2007, Journal of agricultural and food chemistry.

[18]  Y. Surh,et al.  Intracellular signaling network as a prime chemopreventive target of (-)-epigallocatechin gallate. , 2006, Molecular nutrition & food research.

[19]  D Bar-Sagi,et al.  Introduction of unlabeled proteins into living cells by electroporation and isolation of viable protein-loaded cells using dextran-fluorescein isothiocyanate as a marker for protein uptake. , 1991, Analytical biochemistry.

[20]  Kwon-Yong Lee,et al.  Long-term preservation of human saphenous vein by green tea polyphenol under physiological conditions. , 2005, Tissue engineering.

[21]  Y. Fujimura,et al.  A receptor for green tea polyphenol EGCG , 2004, Nature Structural &Molecular Biology.

[22]  C. Schneeberger,et al.  Production and actions of estrogens. , 2002, The New England journal of medicine.

[23]  H. Mukhtar,et al.  Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells , 2003, Oncogene.

[24]  Dongwook Han,et al.  The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide-co-epsilon-caprolactone) as stent-coating materials. , 2008, Biomaterials.

[25]  Chi-Tang Ho,et al.  Trapping reactions of reactive carbonyl species with tea polyphenols in simulated physiological conditions. , 2006, Molecular nutrition & food research.

[26]  F. Nanjo,et al.  Metabolic Fate of (−)-[4-3H]Epigallocatechin Gallate in Rats after Oral Administration , 2001 .

[27]  Hideyuki Ito,et al.  Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. , 1998, Carcinogenesis.

[28]  Mi Hee Lee,et al.  Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor-kappaB down-modulation. , 2006, Biochemical and biophysical research communications.